Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Roka BioScience, Inc. (ROKA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2017 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Sold 74,096 shares
@ $1.03, valued at
$76.3k
Sold 706 shares
@ $1.03, valued at
$727.2
Sold 52,301 shares
@ $0.92, valued at
$48.1k
Sold 498 shares
@ $0.92, valued at
$458.2 |
|
| 08/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2017 |
4
| Doyle Michael P. (Director) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Granted 3,000 options to buy
@ $2.55, valued at
$7.7k
|
|
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2017 |
4
| Mary Beth Duseau (CEO and President) has filed a Form 4 on Roka BioScience, Inc. |
| 03/28/2017 |
4
| Boesgaard Lars (Vice President, CFO) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Granted 54,000 options to buy
@ $3.45, valued at
$186.3k
|
|
| 02/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| VALERIANI NICHOLAS J (Director) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Converted 7,143 shares
@ $7, valued at
$50k
Converted 50 convertible preferred
@ $0 |
|
| 11/10/2016 |
4
| Boesgaard Lars (Vice President, CFO) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Converted 3,572 shares
@ $7, valued at
$25k
Converted 25 convertible preferred
@ $0 |
|
| 11/10/2016 |
4
| THOMAS PAUL (President and CEO) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Converted 7,143 shares
@ $7, valued at
$50k
Converted 50 convertible preferred
@ $0 |
|
| 11/10/2016 |
4
| Mary Beth Duseau (SVP, Chief Commercial Officer) has filed a Form 4 on Roka BioScience, Inc. |
| 10/31/2016 |
4
| TPG Group Holdings (SBS) Advisors, Inc. (10% Owner) has filed a Form 4 on Roka BioScience, Inc. |
| 09/23/2016 |
4
| Weller Harry R (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Roka BioScience, Inc. |
| 09/23/2016 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| MOTT DAVID M (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| KOLLURI KRISHNA KITTU (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| KERINS PATRICK J (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| BARRIS PETER J (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| BARRETT M JAMES (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| NEW ENTERPRISE ASSOCIATES 13 LP (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 4,000 convertible preferred
@ $0.7, valued at
$2.8k
Bought 5,714,286 options to buy
@ $0.7, valued at
$4M
|
|
| 09/23/2016 |
4
| Boesgaard Lars (Vice President, CFO) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 25 convertible preferred
@ $0.7, valued at
$17.5
Bought 35,714 warrants
@ $0.7, valued at
$25k
|
|
| 09/23/2016 |
4
| VALERIANI NICHOLAS J (Director) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 50 convertible preferred
@ $0.7, valued at
$35
Bought 71,429 warrants
@ $0.7, valued at
$50k
|
|
| 09/23/2016 |
4
| Mary Beth Duseau (SVP, Chief Commercial Officer) has filed a Form 4 on Roka BioScience, Inc. |
| 09/23/2016 |
4
| THOMAS PAUL (President and CEO) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 50 convertible preferred
@ $0.7, valued at
$35
Bought 71,429 warrants
@ $0.7, valued at
$50k
|
|
| 09/23/2016 |
4
| SILVERSTEIN JONATHAN (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 3,962 convertible preferred
@ $0
Bought 38 convertible preferred
@ $0
Bought 5,660,377 warrants
@ $0
Bought 53,909 warrants
@ $0 |
|
| 09/23/2016 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Bought 3,962 convertible preferred
@ $0
Bought 38 convertible preferred
@ $0
Bought 5,660,377 warrants
@ $0
Bought 53,909 warrants
@ $0 |
|
|
|
|